Prosecution Insights
Last updated: November 20, 2026

Sarah Pihonak, USPTO Patent Examiner

Listed by the USPTO as PIHONAK, SARAH

Tech Center 1600 • Art Units: 1617 1627

This examiner grants 61% of resolved cases

Analysis

PIHONAK, SARAH works in Tech Center 1600 and Art Unit 1617. The profile covers 1522 resolved cases, with a 61.4% allowance rate, a 42.3% interview lift, and a 1027-day median time to allowance. The large record provides a substantial basis for planning, and the interview result identifies direct examiner engagement as a meaningful prosecution tool.

The leading companies are ThermoLife International LLC, Nevakar Injectables Inc., and The University of British Columbia. The leading firms are BOOTH UDALL, PLC, Adler Pollock & Sheehan P.C., and ARENTFOX SCHIFF LLP. Practitioners should use interviews to focus the dispute, then document agreed or unresolved points in a targeted written response.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

61.4%
Allow Rate
+1.4% vs TC avg
1,563
Total Applications
+42.3%
Interview Lift
1027
Avg Prosecution Days
Based on 1522 resolved cases, 2023–2026

Rejection Statute Breakdown

2.2%
§101 Eligibility
10.3%
§102 Novelty
39.2%
§103 Obviousness
23.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18579786 COMPOSITIONS COMPRISING CONSTITUENTS, DERIVATIVES OR EXTRACTS OF CANNABIS Final Rejection Nicoventures Trading Limited
19556549 AMINO ACID COMPOSITIONS Non-Final OA ThermoLife International, LLC
19556505 AMINO ACID COMPOSITIONS Non-Final OA ThermoLife International, LLC
19556587 AMINO ACID COMPOSITIONS Non-Final OA ThermoLife International, LLC
18035578 A Method of Treating Depression by Immune Modulation Non-Final OA The University of British Columbia
17691745 HETEROAROMATIC ELECTROPHILES AND METHODS OF USING THEREOF Non-Final OA OHIO STATE INNOVATION FOUNDATION
18040515 METHODS AND COMPOSITIONS FOR TREATING CYTOKINE RELEASE SYNDROME Final Rejection Temple University-Of The Commonwealth System of Higher Education

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Sarah Pihonak's allowance rate?

61.4% of resolved applications examined by Sarah Pihonak were allowed (1,522 resolved cases), compared with 34.2% across Art Unit 1617 over the last five years.

Does an interview help with examiner Sarah Pihonak?

This examiner's interview lift is +42.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Sarah Pihonak take to allow a patent?

Applications allowed by Sarah Pihonak took 1,027 days on average from filing to allowance.

Which art unit does examiner Sarah Pihonak work in?

Sarah Pihonak examines applications in Art Unit 1617 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month